Vasopressin Therapy
Scientists at Shinshu University target vasopressin therapy in women
Published in Hematology Week, March 22nd, 2010
Scientists discuss in 'Vasopressin V1a receptor polymorphism and interval walking training effects in middle-aged and older people' new findings in vasopressin therapy. According to recent research from Asahi, Japan, "We assessed whether single nucleotide polymorphism rs1042615 of the vasopressin V1a receptor altered the indices of lifestyle-related diseases in middle-aged and older people (mean±SD: 64±7 years), and, if so, whether it also altered the effects of interval walking training (IWT). CC, CT, and TT carriers of rs1042615 (42, 118, and 64 men, respectively; 113, 263, and 154 women, respectively) performed IWT."
"We included 5 sets of 3-minute fast...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
Source: Hematology Week (2010-03-22)
More Articles from Hematology Week
- Columbia University Medical Center
Acupuncture may relieve joint pain caused by some breast cancer treatments - Research Australia
Snake venom charms science world - Alpha-thalassemia
Research results from Chiang Mai University update knowledge of alpha-thalassemia - American Society of Hematology
Critical Recommendations Unveiled to Respond to National Public Health Crisis: Deep-Vein Thrombosis and Pulmonary Embolism - Apoptosis
Studies from China Medical University in the area of apoptosis described - Biomedical Engineering
New biomedical engineering study results from H.Y. Sun et al described - More from this issue of Hematology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
